| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.098 | 0.005 |
| mRNA | etoposide | CTRPv2 | pan-cancer | AAC | 0.085 | 0.005 |
| mRNA | UNC0321 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.005 |
| mRNA | (5Z)-7-Oxozeaenol | GDSC1000 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.21 | 0.007 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.099 | 0.007 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.008 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.01 |